SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Palatin Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update

Advancing differentiated next-generation MC4R agonists toward first-in-human clinical studies in 202

PTN

Related stories